(Q28138707)

1

0 references

J Peng

2

0 references

G Lee

3

0 references

D H Price

4

0 references

O Flores

Journal of Biological Chemistry

5

0 references

language of work or name

English

0 references

publication date

3 December 1999

0 references

published in

0 references

volume

274

0 references

page(s)

34527-30

0 references

issue

49

0 references

cites work

Unusual nucleic acid binding properties of factor 2, an RNA polymerase II transcript release factor.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.49.34527

DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.49.34527

NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.49.34527

Purification of P-TEFb, a transcription factor required for the transition into productive elongation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.49.34527

Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.49.34527

Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.49.34527

The transcriptional inhibitors, actinomycin D and alpha-amanitin, activate the HIV-1 promoter and favor phosphorylation of the RNA polymerase II C-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.49.34527

P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.49.34527

Host-cell positive transcription elongation factor b kinase activity is essential and limiting for HIV type 1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.49.34527

Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.49.34527

Identification of multiple cyclin subunits of human P-TEFb

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.49.34527

Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.49.34527

Human cyclin K, a novel RNA polymerase II-associated cyclin possessing both carboxy-terminal domain kinase and Cdk-activating kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.49.34527

A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.49.34527

The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.49.34527

Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.49.34527

Upregulation of cyclin T1/CDK9 complexes during T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.49.34527